← Back to Search

Contact Lenses

Total30 Sphere Contact Lenses for Dry Eye Syndrome

N/A
Waitlist Available
Led By Andrew D Pucker, OD, MS, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Astigmatism better than or equal to 0.50 D in each eye
Minimally symptomatic as based upon Contact Lens Dry Eye Questionnaire scores (≤10)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

The purpose of this study is to map comfort over the full wear day in established, asymptomatic, soft CL wearers who are refit in Total30 Sphere CLs.

Eligible Conditions
  • Contact Lens Complication
  • Dry Eye Syndrome

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual Analog Scale (VAS) Ocular Comfort

Trial Design

1Treatment groups
Experimental Treatment
Group I: Total30 Sphere Contact LensesExperimental Treatment1 Intervention
All qualified participants will be refit into Total30 Sphere contact lenses.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Total30 Sphere Contact Lenses
2022
N/A
~50

Find a Location

Who is running the clinical trial?

Alcon ResearchIndustry Sponsor
702 Previous Clinical Trials
124,383 Total Patients Enrolled
University of Alabama at BirminghamLead Sponsor
1,565 Previous Clinical Trials
2,268,310 Total Patients Enrolled
Andrew D Pucker, OD, MS, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~15 spots leftby Mar 2025